Abstract
Aims: Lactic acid bacteria (LAB) are known to have antitumoral properties, although the intrinsic mechanisms responsible for the execution of this activity are poorly understood. Here, we investigated the ability of concentrated supernatants from Lactobacillus plantarum to promote cell death in a human promyelocytic cell line.
Methods and Results: We aim to test the hypothesis that concentrated supernatants from Lact. plantarum at 5, 50 or 100 μg/ml for 24 h exert cytotoxic effects on HL-60 cells. Accumulation of reactive oxygen species (ROS) was diminished and nuclear staining with Hoechst 33342 and propidium iodide (PI) determined a necrotic induction in a concentrationdependent sequence. Concentrated supernatants did not modify or reduced the activity of caspase-3. The assessment of phosphatidylserine externalization by annexin V/PI double staining led to a necrotic state, but the treatment did not produce a dissipation of mitochondrial membrane potential (ΔΨm), whereas cell cycle analysis revealed that concentrated supernatants failed to significantly enhance the population of HL-60 cells in the hypodiploid (sub-G1) fraction.
Conclusions: Concentrated supernatants from Lact. plantarum are capable of inducing necrosis rather than apoptosis at high doses in a promyelocytic cell line.
Significance and Impact of the Study: Here, we demonstrate the cytotoxic properties of concentrated supernatants from Lact. plantarum on a tumor cell line, and then, to open the possibility to analyze the chemical composition to elucidate the bioactive molecules.
Keywords: Cell death, lactic acid bacteria, Lactobacillus plantarum, necrosis, probiotics.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Culture Supernatants from Lactobacillus plantarum Induce Necrosis on a Human Promyelocytic Leukemia Cell Line
Volume: 13 Issue: 2
Author(s): Elena Puertollano, Gerardo Alvarez de Cienfuegos, Alfonso Ruiz-Bravo, Manuel A. de Pablo and Maria A. Puertollano
Affiliation:
Keywords: Cell death, lactic acid bacteria, Lactobacillus plantarum, necrosis, probiotics.
Abstract: Aims: Lactic acid bacteria (LAB) are known to have antitumoral properties, although the intrinsic mechanisms responsible for the execution of this activity are poorly understood. Here, we investigated the ability of concentrated supernatants from Lactobacillus plantarum to promote cell death in a human promyelocytic cell line.
Methods and Results: We aim to test the hypothesis that concentrated supernatants from Lact. plantarum at 5, 50 or 100 μg/ml for 24 h exert cytotoxic effects on HL-60 cells. Accumulation of reactive oxygen species (ROS) was diminished and nuclear staining with Hoechst 33342 and propidium iodide (PI) determined a necrotic induction in a concentrationdependent sequence. Concentrated supernatants did not modify or reduced the activity of caspase-3. The assessment of phosphatidylserine externalization by annexin V/PI double staining led to a necrotic state, but the treatment did not produce a dissipation of mitochondrial membrane potential (ΔΨm), whereas cell cycle analysis revealed that concentrated supernatants failed to significantly enhance the population of HL-60 cells in the hypodiploid (sub-G1) fraction.
Conclusions: Concentrated supernatants from Lact. plantarum are capable of inducing necrosis rather than apoptosis at high doses in a promyelocytic cell line.
Significance and Impact of the Study: Here, we demonstrate the cytotoxic properties of concentrated supernatants from Lact. plantarum on a tumor cell line, and then, to open the possibility to analyze the chemical composition to elucidate the bioactive molecules.
Export Options
About this article
Cite this article as:
Puertollano Elena, Cienfuegos de Gerardo Alvarez, Ruiz-Bravo Alfonso, Pablo de Manuel A. and Puertollano A. Maria, Culture Supernatants from Lactobacillus plantarum Induce Necrosis on a Human Promyelocytic Leukemia Cell Line, Endocrine, Metabolic & Immune Disorders - Drug Targets 2013; 13 (2) . https://dx.doi.org/10.2174/1871530311313020008
DOI https://dx.doi.org/10.2174/1871530311313020008 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New, Substituted Derivatives of Dicarboximides and their Cytotoxic Properties
Anti-Cancer Agents in Medicinal Chemistry New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives
Current Topics in Medicinal Chemistry Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Current Medicinal Chemistry Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Mini-Reviews in Organic Chemistry The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells
Current Cancer Drug Targets Appreciating the Balance between Classical Interleukin (IL)-6 Receptor Signaling and IL-6 Trans-Signaling: Implications for Arthritis Progression
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biotechnological Production of Taxol and Related Taxoids: Current State and Prospects
Anti-Cancer Agents in Medicinal Chemistry Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry Alternative Splicing and Tumor Progression
Current Genomics Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Current Cancer Therapy Reviews Flavonoids in Human Health: From Structure to Biological Activity
Current Nutrition & Food Science Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy
Current Cancer Drug Targets A Discussion of MicroRNAs in Cancers
Current Bioinformatics Recent Patents Concerning Diagnostic and Therapeutic Applications of Aberrantly Methylated Sequences in Pancreatic Cancer
Recent Patents on DNA & Gene Sequences Biological and Pharmacological Roles of N6-Isopentenyladenosine: An Emerging Anticancer Drug
Anti-Cancer Agents in Medicinal Chemistry Low-Dose Methotrexate (LD-MTX) in Rheumatology Practice - A Most Widely Misunderstood Drug
Current Rheumatology Reviews Effects of Paliroden (SR57667B) and Xaliproden on Adult Brain Neurogenesis
Current Alzheimer Research Signal transduction in Acute Myeloid Leukemia – Implications for Novel Therapeutic Concepts.
Current Cancer Drug Targets